Kenneth T. Mills Regenxbio Inc. (RGNX) insider trading activity

Kenneth T. Mills is of REGENXBIO Inc.. Currently has a direct ownership of 444,351 shares of RGNX, which is worth approximately $4.15 Million. The most recent transaction as insider was on Jan 03, 2022, when has been sold 35,796 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 444K

8.9% 3M change

47.85% 12M change

Total Value Held $4.15 Million

Kenneth T. Mills Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2022	BUY Grant, award, or other acquisition	-	35,796 Added 10.36%	309,844 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$118,897 $32.7 p/Share	3,636 Reduced 1.31%	274,048 Common Stock
Dec 02 2021	SELL Bona fide gift	-	3,300 Reduced 1.17%	277,684 Common Stock
Nov 08 2021	SELL Open market or private sale	$60,000 $40.0 p/Share	1,500 Reduced 0.53%	280,984 Common Stock
Nov 08 2021	BUY Exercise of conversion of derivative security	$5,640 $3.76 p/Share	1,500 Added 0.53%	282,484 Common Stock
Sep 27 2021	SELL Open market or private sale	$63,285 $42.19 p/Share	1,500 Reduced 0.53%	280,984 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$5,640 $3.76 p/Share	1,500 Added 0.53%	282,484 Common Stock
Sep 14 2021	SELL Open market or private sale	$1,578,850 $45.11 p/Share	35,000 Reduced 11.08%	280,984 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$80,850 $2.31 p/Share	35,000 Added 9.97%	315,984 Common Stock
Sep 13 2021	SELL Open market or private sale	$120,060 $40.02 p/Share	3,000 Reduced 1.06%	280,984 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$11,280 $3.76 p/Share	3,000 Added 1.05%	283,984 Common Stock
Jun 25 2021	SELL Open market or private sale	$60,375 $40.25 p/Share	1,500 Reduced 0.53%	280,984 Common Stock
Jun 25 2021	BUY Exercise of conversion of derivative security	$5,640 $3.76 p/Share	1,500 Added 0.53%	282,484 Common Stock
Jun 24 2021	SELL Open market or private sale	$180,090 $40.02 p/Share	4,500 Reduced 1.58%	280,984 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	$16,920 $3.76 p/Share	4,500 Added 1.55%	285,484 Common Stock
Feb 25 2021	SELL Open market or private sale	$61,155 $40.77 p/Share	1,500 Reduced 0.53%	280,984 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$1,275 $0.85 p/Share	1,500 Added 0.53%	282,484 Common Stock
Jan 25 2021	SELL Open market or private sale	$285,285 $43.89 p/Share	6,500 Reduced 2.26%	280,984 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$5,525 $0.85 p/Share	6,500 Added 2.21%	287,484 Common Stock
Jan 07 2021	SELL Open market or private sale	$75,015 $50.01 p/Share	1,500 Reduced 0.53%	281,984 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	$1,275 $0.85 p/Share	1,500 Added 0.53%	283,484 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	40,984 Added 12.69%	281,984 Common Stock
Dec 28 2020	SELL Open market or private sale	$317,330 $48.82 p/Share	6,500 Reduced 2.63%	241,000 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$5,525 $0.85 p/Share	6,500 Added 2.56%	247,500 Common Stock
Dec 23 2020	SELL Open market or private sale	$225,000 $50.0 p/Share	4,500 Reduced 1.83%	241,000 Common Stock

KTM

Kenneth T. Mills

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Value

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX

Account